6533b834fe1ef96bd129e05f

RESEARCH PRODUCT

Haploinsufficiency of ARFGEF1 is associated with developmental delay, intellectual disability, and epilepsy with variable expressivity

Jennifer E. PoseyArthur SorlinFatema Al ZahraniJérôme GovinNathalie MarleThomas BesnardAnne-sophie Denommé-pichonSebastien MouttonJill A. MaddenPatrick CallierChristophe PhilippeEleina M. EnglandJulian DelanneBenjamin CognéAnge-line BruelPankaj B. AgrawalMaria IasconeTabib DabirSolène ConradThierry GautierQuentin ThomasNebal Waill SaadiLydie BurglenLydie BurglenLaurence DuplombFowzan S. AlkurayaYannis DuffourdSylvie NguyenSiddharth BankaSiddharth BankaDana MarafiDana MarafiMarjolaine WillemsChristel Thauvin-robinetPhilippine GarretLaurence FaivreFrédéric Tran Mau-themAntonio VitobelloJames R. LupskiAdam JacksonDiana RodriguezAlice MasurelRomano TenconiMartin ChevarinBertand Isidor

subject

0301 basic medicineGeneticsCandidate geneHeterozygoteEpilepsyADP ribosylation factorIn silicoHeterozygote advantageHaploinsufficiency030105 genetics & heredityBiologymedicine.disease03 medical and health sciencesEpilepsy030104 developmental biologyIntellectual DisabilitymedicineGuanine Nucleotide Exchange FactorsHumansGuanine nucleotide exchange factorHaploinsufficiencyGenetics (clinical)Minigene

description

PURPOSE: ADP ribosylation factor guanine nucleotide exchange factors (ARFGEFs) are a family of proteins implicated in cellular trafficking between the Golgi apparatus and the plasma membrane through vesicle formation. Among them is ARFGEF1/BIG1, a protein involved in axon elongation, neurite development, and polarization processes. ARFGEF1 has been previously suggested as a candidate gene for different types of epilepsies, although its implication in human disease has not been well characterized.METHODS: International data sharing, in silico predictions, and in vitro assays with minigene study, western blot analyses, and RNA sequencing.RESULTS: We identified 13 individuals with heterozygous likely pathogenic variants in ARFGEF1. These individuals displayed congruent clinical features of developmental delay, behavioral problems, abnormal findings on brain magnetic resonance image (MRI), and epilepsy for almost half of them. While nearly half of the cohort carried de novo variants, at least 40% of variants were inherited from mildly affected parents who were clinically re-evaluated by reverse phenotyping. Our in silico predictions and in vitro assays support the contention that ARFGEF1-related conditions are caused by haploinsufficiency, and are transmitted in an autosomal dominant fashion with variable expressivity.CONCLUSION: We provide evidence that loss-of-function variants in ARFGEF1 are implicated in sporadic and familial cases of developmental delay with or without epilepsy.

10.1038/s41436-021-01218-6http://dx.doi.org/10.1038/s41436-021-01218-6